Vimarsana
Biggest News Aggregation in the World

Page 31 - Adverse Effects News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adverse Effects. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adverse Effects Today - Breaking & Trending Today

No Longer a Death Sentence, HIV Diagnosis Still Hits Hard - Vimarsana News

No Longer a Death Sentence, HIV Diagnosis Still Hits Hard

HIV can take an emotional toll on patients whether it was diagnosed days ago or decades before, but the issues patients must contend with have changed over time.

Do Outcomes Vary by Race in Women With Obstructive CAD? - Vimarsana News

Do Outcomes Vary by Race in Women With Obstructive CAD?

No racial or ethnic disparities in long-term adverse effects or cardiovascular mortality were seen among women with obstructive coronary artery disease treated in university or academic centers.

Successful Bladder Cancer Programs Rely on Old Pillars, New Innovations - Vimarsana News

Successful Bladder Cancer Programs Rely on Old Pillars, New Innovations

Building a successful bladder cancer program requires clinicians to employ a multifaceted approach that prioritizes good surgical practices, embraces immunotherapies with an understanding of the adverse effects that can accompany them, and being up to date in terms of options for patients.

JAK Inhibitor Effects in RA Confirmed in Real-World Study - Vimarsana News

JAK Inhibitor Effects in RA Confirmed in Real-World Study

The safety and efficacy of tofacitinib, baricitinib, peficitinib, and upadacitinib were similar in a multicenter study of more than 600 adults with rheumatoid arthritis.

ADC Shows Survival Benefit in Mets Cervical Cancer - Vimarsana News

ADC Shows Survival Benefit in Mets Cervical Cancer

The antibody-drug conjugate tisotumab vedotin led to improved outcomes compared with chemotherapy in second- or third-line treatment of recurrent/metastatic cervical cancer.